PAYS

Business Context and Reporting Period

Company: 3PEA International, Inc. (Note: Metadata listed "Paysign, Inc." but filing is for 3PEA International, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2011
Business Overview: 3PEA is a transaction-based solutions provider focusing on secure payment solutions, specifically prepaid debit cards (stored value cards) for healthcare, pharmaceutical, and financial applications. The company manages the full lifecycle of debit cards, including design, production, and distribution.

Key Financial Metrics

Liquidity Note: The company holds significant restricted cash ($2.95M) which is offset by a corresponding "Customer card funding" liability. Unrestricted cash is $83,919.

Material Changes vs. Prior Period

• Revenue Growth: Revenues increased by $488,705 (109%) compared to Q1 2010, driven by an increase in program card load transactions (approx. 164,000 vs. 140,000) and continued market acceptance of the processing platform.
• Profitability Turnaround: The company moved from an operating loss of $34,660 in Q1 2010 to an operating income of $22,157 in Q1 2011. Net income improved by $53,844, turning a net loss of $47,402 into a net income of $6,442.
• Margin Compression: While revenue grew, the gross margin percentage declined from ~30% in 2010 to ~20% in 2011 due to higher transaction processing and card production costs relative to revenue.
• Balance Sheet Improvement: Total current liabilities decreased by approximately $3 million, primarily due to a reduction in customer card funding liabilities and accounts payable. Accounts receivable dropped significantly from $1.64M to $62k, indicating strong collections.

Outlook, Risks, and Management Commentary

• Going Concern Warning: Management has raised substantial doubt about the company's ability to continue as a going concern. The company has an accumulated deficit of approximately $8.04 million and insufficient operating capital to sustain activities for the next 12 months without additional financing.
• Short-Term Outlook: Management expects revenues to remain flat or trend downward in the short term due to declining average program sizes caused by economic conditions, despite gaining new clients.
• Long-Term Outlook: Revenues are expected to trend upward as the economy improves and new debit card products are rolled out.
• Capital Needs: The company is attempting to raise capital via a private placement of preferred stock and plans to convert delinquent accounts payable and notes into equity. Failure to secure capital may delay expansion into new markets.
• Debt Status: The company has substantial indebtedness, including $891,653 in accounts payable (many past due) and $2.49M in loans payable classified as current. Management is relying on creditor forbearance and debt-to-equity conversions.

Investor Verification Checklist

• Going Concern Status: Verify the status of the private placement offering and the likelihood of debt-to-equity conversions with creditors.
• Restricted Cash: Confirm the nature of the $2.95M restricted cash and the corresponding liability to ensure it is not available for general operations.
• Revenue Volatility: Assess the sustainability of revenue given the company's admission that pharmaceutical client programs fluctuate widely and average program sizes are declining.
• Delinquent Payables: Review the $891k in accounts payable to understand the risk of legal action from creditors if debt conversion fails.
• Merger Activity: Note the issuance of stock related to the merger with Wow Technologies, Inc., and verify any ongoing integration costs or benefits.